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This study showed that a protein II (Pll) of Neisseria gonorrhoeae FA1090
appeared to act as a mediator of attachment to HeLa cells. Two colony variants of
FA1090 were selected. Both gonococcal variants were nonpiliated, but one con-
tained a PIT and the other did not. A monoclonal antibody (1090-10.1), which was
directed against the PII, inhibited the apparent PII-mediated attachment to HeLa
cells. Antibodies produced from clone 1035-4, which had no PII specificity, did
not inhibit the attachment and were used as controls. Inhibition of gonococcal
attachment by the 1090-10.1 monoclonal antibodies was demonstrated by fluores-
cent microscopy analysis. Monoclonal antibody 1090-10.1 appeared to cause
agglutination of the PII-containing organism. To block the clumping caused by the
PII-specific monoclonal antibodies, Fab fragments of goat anti-mouse IgG were
incubated with gonococci and the 1090-10.1 monoclonal antibodies. The results
showed that the goat anti-mouse IgG Fab fragments partially blocked the
agglutination caused by the PII-specific monoclonal antibody. The effect of the
1090-10.1 antibodies on attachment was also determined by monitoring the HeLa
cells with attached iodinated gonococci. The monoclonal antibody appeared to
inhibit the PII-mediated attachment.
In Neisseria gonorrhoeae, pili seem to func-
tion as primary effectors of attachmentt to eu-
caryotic cells (16, 17). The presence of a nonpi-
lus surface protein, protein II (Pll), also
correlates with attachment (20). A strain of N.
gonorrhoeae can express several Plls associated
with various degrees of colony opacity (14), and
at least one PII appears to be associated with
opaque colony phenotype. Opaque colony vari-
ants of strain F62 attach better to HeLa 229 and
Flow 2000 cells than do transparent colony
variants (4). One PII (leukocyte association fac-
tor), from strain MS11, promotes attachment to
leukocytes (6, 7, 17). Other PIIs promote attach-
ment to other types of eucaryotic cells (9, 15).
The attachment function of a surface protein,
such as PIT or pili, can be studied by showing
that antibodies directed against the protein in-
hibit attachment (13, 21). Antiserum prepared
against leukocyte association factor inhibited
gonococcal attachment to polymorphonuclear
cells (7). Also, antiserum prepared against pili
t Present address: Naval Biosciences Laboratory, Naval
Supply Center, Oakland, CA 94625.
inhibited attachment to buccal epithelial cells
(18).
Our studies have identified a PII in gonococ-
cus strain FA1090 which may act as a mediator
of attachment to HeLa cells. We employed a
highly specific monoclonal antibody (11) direct-
ed against the PIT in our attachment assays. The
influence of the monoclonal antibodies on at-
tachment was studied by fluorescent microsco-
py and radiolabel techniques. The results
showed that the PII-specific monoclonal anti-
body inhibited the PII-mediated attachment to
HeLa cells.
MATERIALS AND METHODS
SDS-PAGE. Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) was performed as
described by Laemmli (8). An acrylamide concentra-
tion of 12.5% was used in the separating gel. The
molecular weight markers (BioRad Laboratories) as
well as the N. gonorrhoeae FA1090 variants were
solubilized at 37 or 100°C in SDS-PAGE sample buffer
(0.125 M Tris buffer [pH 6.8], 2.5% SDS, 25% glycer-
ol, 2.5% 2-mercaptoethanol, 0.001% bromophenol
blue). The molecular weight markers were: bovine
serum albumin, 66.2 kilodaltons (kDa); ovalbumin, 45
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kDa; carbonic anhydrase, 31 kDa; soybean trypsin
inhibitor, 21.5 kDa; and lysozyme, 14.4 kDa.
Iodination procedures. Staphylococcus aureus pro-
tein A and the SDS-PAGE molecular weight markers
were iodinated by the chloramine-T method (1). Free
iodine was removed by gel filtration through a Sepha-
dex G-25 column, which was equilibrated in phos-
phate-buffered saline (PBS). Intact gonococci from the
two colony variants of strain FA1090 were iodinated
with a lactoperoxidase-catalyzed reaction (19). Brief-
ly, 0.1 mCi of 1251, 5 mM P-D-glucose, 20 ,ug of
lactoperoxidase, and 0.2 U of glucose oxidase in 1 ml
of PBS were combined with intact gonococci in a total
volume of 1 ml for 10 min at room temperature. The
gonococci were centrifuged and washed in PBS to
remove unbound iodine.
Hybridoma selection and antibody production. Hy-
bridomas were produced and screened, ascites were
induced with hybridoma clones 1090-10.1 and 1035-4,
and ascitic fluids were collected as previously de-
scribed (11).
Antibody specificity assay. Proteins were transferred
from SDS-polyacrylamide gels to nitrocellulose paper
electrophoretically, overnight, at 100 mA in a Trans-
Blot apparatus (BioLad Laboratories). The "Western
blotting" procedure of Burnette (2) was used, except
that PBS was substituted for Tris-saline. Iodinated
molecular weight markers were not incubated with
antibody. The X-ray film was exposed to the antigen-
antibody-['125I]protein A sandwich for 2 days at -70°C
with enhancement by a Dupont Cronex intensifying
screen.
Gonococci. N. gonorrhoeae FA1090 was grown on
agar at 37°C in the presence of 5% CO2 (5). Strain
FA1090 expressed at least six Plls (W. J. Black, R. S.
Schwalbe, I. Nachamkin, and J. G. Cannon, Abstr.
Annu. Meet. Am. Soc. Microbiol. 1982, D7, p. 48;
manuscript in preparation). For our studies, two colo-
ny variants of strain FA1090 were selected. One
colony type was transparent, whereas the other
formed slightly more opaque colonies. Gonococci
from the colonies that were slightly more opaque
contained a Pll (designated strain FA1090 PII+). Gon-
ococci from the other colony variant did not contain a
PII (designated strain FA1090 PII-). Colonies were
harvested after 16 to 20 h of growth.
N. gonorrhoeae can shift colony phenotype and PII
composition with a moderately high frequency (14).
Consequently, we monitored the PII composition for
the PII+ and PIP- variants used in each experiment.
The data reported in this paper are from experiments
in which the PII+ variant did have a PlI as demonstrat-
ed by SDS-PAGE, Western blotting, and autoradiog-
raphy assays. The PIP- variant did not have Plls as
determined by these assays.
The large-diameter colony types selected for both
the PII+ and PlI- variants represented nonpiliated
gonococci. Organisms from the same strain FA1090
colony types used in this study were subjected to SDS-
PAGE and transferred to nitrocellulose paper for an
electroblotting assay. Rabbit antibody directed against
gonococcal strain MS11 pilus cyanogen bromide frag-
ment 2 (courtesy of Gary K. Schoolnik, Stanford
University) was iodinated and used to react with the
strain FA1090 preparations. The resultant autoradio-
graphs showed no evidence of pili. As controls, gono-
cocci from small-colony types (piliated) but not large-
colony types (nonpiliated) of many other strains of
gonococci were prepared in the same manner. Reac-
tions with pilus protein bands were routinely seen only
on autoradiographs of the gonococci from the small-
colony types. The minimal amount of strain FA1090
pilus protein required for a positive reaction was not
determined.
HeLa cells. HeLa 229 cells were maintained in Eagle
minimal essential medium with 10% heat-inactivated
calf serum, 2.5 ,ug of fungizone per ml, 50 ,ug of
gentamicin per ml, and 100 U of penicillin per ml (3).
HeLa cells were removed from two 150-cm2 flasks
with 0.1 mg of pancreatin per ml, 0.6 mg of trypsin per
ml, and 0.5 mg ofEDTA per ml, and then suspended at
1 x 105 to 3 x 105 cells per ml in antibiotic-free
minimal medium with serum. Portions (1 ml) of the
cells were placed on cover slips in Leighton tubes. The
cells were incubated at 37°C in 5% CO2 and air for 24 h
to allow formation of monolayers.
Antibody-binding assay. Duplicate samples of strain
FA1090 PII+ and PIP- variants (2 x 10' CFU/ml) were
incubated with concentrations ranging between 0.03
and 1.0 mg of ascitic fluid (clone 1090-10.1) per ml.
After 90 min at room temperature, the organisms were
centrifuged and washed. '251-labeled protein A (7 x
106 cpm) was added to each tube and incubated for 30
min at room temperature. The tubes were washed
twice with medium 199 before being counted. The
average number of counts per minute was calculated
for each concentration of ascitic fluid.
Fab fragment preparation. Fab fragments of goat
anti-mouse IgG (GAM) (Cappel Laboratories) were
produced by a pepsin digest as outlined by Nisonoff et
al. (12). The peptic digest was treated with 20 mM
iodoacetamide for 60 min at room temperature before
being purified on a Sephadex G-75 column. Protein
concentrations were determined by the method of
Lowry et al. (10).
Attachment assays. (i) '2MI-labeled gonococci. Four
inocula were prepared for each set of experiments.
125I-labeled intact gonococci, strain FA1090 PII+ or
FA1090 PIP-, were incubated with monoclonal anti-
body 1090-10.1 or 1035-4 for 90 min at room tempera-
ture. The inocula were centrifuged, suspended in
medium 199, and diluted 10-fold in medium 199. Cover
slips of HeLa cells were washed in medium 199, and
then 2 ml of an inoculum was added to each cover slip.
The cover slips were incubated without shaking at
37°C for 30 min, the inocula were removed, and the
cover slips were washed and counted.
The HeLa cells from one or two cover slips incubat-
ed with inoculum or medium alone were scraped off
with a rubber policeman and dispersed in 1 ml of the
pancreatin-trypsin-EDTA solution. The cells were
counted with a hemacytometer, and an average HeLa
cell count was determined. There were approximately
105 HeLa cells removed per cover slip, which was
about one-third the number used to seed the cover
slips. The number of HeLa cells incubated with the
gonococcal inocula did not vary more than the average
+ the standard deviation from the number of HeLa
cells incubated with medium alone.
The counts per minute and CFU per milliliter for
samples of each of the inocula were also determined.
Samples of the organisms before iodination were as-
sayed in the immunoblot assay described above.
(ii) GAM Fab fragment effects on monoclonal anti-
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body action. An assay was also performed as outlined
above, except that GAM Fab (0.5 mg/ml, final concen-
tration) was added to the four inocula: strains FA1090
PII+ and PII- each with monoclonal antibody 1090-
10.1 or 1035-4. The GAM Fab inocula were incubated
at room temperature for 30 min and vortexed. The
remainder of the attachment assay was performed as
described above. One GAM Fab preparation was used
for two experiments, and a second preparation was
used for a third set of experiments.
(iii) Light microscopy analysis. Solutions (2 x 108
CFU/ml) of the strain FA1090 colony variants were
prepared in PBS. The gonococci (0.6 ml) were preincu-
bated with 0.025 ml of monoclonal antibody 1090-10.1
or 1035-4 for 90 min at 22°C with periodic shaking. The
inocula were diluted 1:10 and incubated with
prewashed cover slips coated with nonconfluent HeLa
cells (2 x 104) for 30 min at 37°C without shaking.
After the cover slips were washed, the HeLa cells and
gonococci were fixed in methanol. The cover slips
were then stained with 0.005% 3-bisdimethylaminoa-
cridinium chloride (acridine orange) in 0.15 M sodium
acetate buffer (pH 4.0) at room temperature for 15 min.
The numbers of attached gonococci were counted with
a microscope with incident fluorescent light at x 1,000
magnification. The CFU per milliliter for each inocu-
lum was determined for each set of experiments.
RESULTS
Two variants of N. gonorrhoeae strain
FA1090 were selected for study. Based on their
SDS-PAGE profiles (Fig. 1), the variant of strain
FA1090 that formed slightly more opaque colo-
nies contained a heat-modifiable protein with an






FIG. 1. Coomassie blue R-250-stained, 12.5%
SDS-polyacrylamide gel of strain FA1090 organisms.
Lanes: A, molecular weight standards; B, PlIl variant
(2 h at 37°C); C, PII+ variant (5 min at 100°C); D, PII-
variant (2 h at 370C); E, PIP- variant (5 min at 100°C).
The standards and the bacteria were solubilized in
SDS-PAGE sample buffer at the temperature and for
the time indicated in parentheses.
INFECT. IMMUN.
apparent molecular weight of 30,000 and was
designated PII+. This PII corresponded with the
PIlb-containing variant of strain FA1090 (W. J.
Black et al., Abstr. 82nd Annu. Meet. Am. Soc.
Microbiol., p. 48).
The lactoperoxidase-catalyzed iodination of
intact organisms and their analysis by autoradi-
ography after SDS-PAGE demonstrated that the
PII from the PlIl variant was a surface protein
(Fig. 2).
The mouse monoclonal antibody 1090-10.1
was specific for the PII of strain FA1090 PII+.
This was demonstrated by a Western blotting
reaction and autoradiography (Fig. 3). There
was no reaction between the proteins expressed
by strain FA1090 PIP and monoclonal antibody
1090-10.1, nor was there a reaction between
monoclonal antibody 1035-4 and the Pll of either
variant by the Western blot assay.
The concentration of ascitic fluid protein
(clone 1090-10.1) for maximal binding to the
PII+ variant (_107 CFU) was determined to be
0.34 mg of protein per ml. The PIP- variant did
not bind ascitic fluid proteins. At higher concen-
trations of ascitic fluid, a decrease in the gono-
coccal-associated 1251 counts per minute per
CFU was observed. The 0.34-mg/ml concentra-
tion of ascitic fluid protein was maintained in the
attachment assays. Ascitic fluid protein (clone
1035-4) did not bind to PII+ organisms in this
assay.
The effect of monoclonal antibody 1090-10.1
on the attachment of strain FA1090 organisms to
HeLa cells was studied with radiolabeled gono-
cocci. Monoclonal antibody 1090-10.1 either had
no effect or appeared to cause an increase in
gonococcal binding of the PII+ organisms in
comparison with the control antibody 1035-4
(Table 1). Also, the number of PII+ organisms
that attached when treated with monoclonal
antibody 1090-10.1 was greater than the number
that attached without it (data not shown). This
apparent stimulation of attachment was due to
the clumping or agglutination of the bacteria
before their attachment to HeLa cells, as evi-
denced by at least a 50% drop in their numbers
in the inoculum for the PlIl organisms treated
with antibody 1090-10.1 as compared with the
numbers in antibody 1035-4 treated controls.
To help counteract the clumping, GAM Fab
were added to the four inocula before addition to
HeLa cells. Monoclonal antibody 1090-10.1-
treated strain FA1090 PII+ cell attachment was
significantly decreased (P < 0.05) in two of the
three experiments compared with the experi-
ments in which strain FA1090 PII+ was incubat-
ed with control monoclonal antibody 1035-4 and
GAM Fab (Table 1). Attachment by the control
Pll- variant was not affected by either antibody
(Table 1).
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FIG. 2. Autoradiograph of iodinated strain FA1090
PII+ and FA1090 PIP- gonococci. Lactoperoxidase-
catalyzed iodination was performed on whole bacteria
in PBS. The gonococci were washed and then solubi-
lized in SDS-PAGE sample buffer before a sample of
each variant (105 cpm) was applied to a 12.5% SDS-
polyacrylamide gel. Labeled proteins were detected
by autoradiography (24 h) of the dried gel. Lanes: PIP-
solubilized at 37 (A) or 100°C (B); PII+ solubilized at
37 (C) or 100°C (D).
ococci as well as a lower number of bound
gonococcal units per HeLa cell (Table 2).
DISCUSSION
N. gonorrhoeae Plls are putative attachment
effectors for eucaryotic cells (7, 17, 20). Our
investigation has provided evidence that a PII of
N. gonorrhoeae FA1090 may act as an attach-
ment effector to HeLa cells. The results meet
the criteria indicating protein-mediated attach-
ment as outlined by Watt et al. (21). First, the
protein must be a surface component. The 30
kDa Pll of N. gonorrhoeae FA1090 is a surface
protein, as evidenced by the 1251 labeling of
intact organisms (Fig. 2).
A second criterion is that the bacteria which
do not have the surface protein do not attach.
The number of strain FA1090 Pll- units which
attached to the HeLa cells was less than one-half
that for the PII' variants (1.64 versus 3.75) in
the presence of control antibody. The number of
attached strain FA1090 PII- units was not af-
fected by either antibody (Table 2), suggesting
that the PII could enhance attachment. The
radiolabel studies were not as conclusive, per-
haps due to nonspecific or PII-mediated aggre-
gation or clumping of the PII+ variants. This
clumping would have yielded a decreased num-
ber of CFU per milliliter, resulting in a de-
creased number of gonococcal units available
for binding while increasing the radioactivity
count in the inoculum. Calculations of the per-
cent inoculum bound for PII+ organisms yielded
To quantitate the clumping of strain FA1090
PII+, HeLa cells and attached gonococci were
counted after being stained with acridine orange
by using fluorescent microscopy. A gonococcal
unit was a single organism, a pair, or a clump. It
was apparent that the number of gonococci per
clump was greater for monoclonal antibody
1090-10.1-treated strain FA1090 Pll+ than for
the other three inocula (Table 2). For example,
the percentage of gonococcal units with 16 or
more organisms was 15 and 0% for the antibody
1090-10.1-treated PII+ and the control antibody,
respectively. Also, the number of attached PII+
organisms after treatment with monoclonal anti-
body 1090-10.1 was decreased (1.66 versus 3.75
U) compared with the number of gonococcal
units per HeLa cell after incubation of the
organisms with control monoclonal antibody
1035-4 (Table 2). A similar number of strain
FA1090 PII- gonococcal units attached after
incubation with either antibody. To inhibit
clumping or agglutination due to the PIT-specific
antibody, GAM Fab were added to the strain
FA1090 Pll+ and antibody 1090-10.1 inoculum,
yielding a decreased percentage of clumped gon-
A B C D E
66K-
45 K-




FIG. 3. Autoradiograph of the Western blotting
reaction between strain FA1090 organisms and mono-
clonal antibody 1090-10.1 The strain FA1090 proteins
from an SDS-polyacrylamide gel (Fig. 1) were trans-
ferred to nitrocellulose paper. The Western blotting
assay for reactive antigens employed the Pll-specific
monoclonal antibody 1090-10.1. Lanes: (A) 125I-la-
beled molecular weight markers not exposed to anti-
bodies; PII+ solubilized at (B) 37 or (C) 100°C; and
PIP- solubilized at (D) 37 or (E) 100°C.
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TABLE 1. Attachment of radiolabeled gonococci to
HeLa cells
% Inoculum bound' ± SD
Strain Expt with monoclonal antibody:
(treatment) no.
1035-4 1090-10.1
FA1090 PII+ 1 1.5 ± 0.21 1.7 ± 0.17
2 1.3 ± 0.07 1.7 ± 0.04
3 1.4 ± 0.20 1.2 ± 0.22
FA1090 PIP- 1 0.9 ± 0.11 0.9 ± 0.18
2 1.0 ± 0.13 1.2 ± 0.12
3 1.0 ± 0.09 0.9 ± 0.16
FA1090 PII+ 1 1.9 ± 0.22 1.0 ± 0.38
(GAM Fab)b 2 1.2 ± 0.05 0.7 ± 0.17
3 2.2 ± 0.19 2.0 ± 0.19
FA1090 PII- 1 0.9 ± 0.16 1.0 ± 0.18
(GAM Fab) 2 0.8 ± 0.09 0.8 ± 0.12
3 1.5 ± 0.22 1.5 ± 0.22
a Percent inoculum bound values were calculated as
([counts per minute per cover slip] x 100)/([2 ml]
[average counts per minute per milliliter of inoculum]).
Each value is the average of four to five cover slips.
b The difference between the mean percent inocu-
lum bound with antibody 1035-4 and antibody 1090-
10.1 was significant by Student's t test for experiments
1 and 2 (P < 0.025), but not for experiment 3.
a lower value than would have been obtained
had it been possible to count individual bacteria.
Thus, a smaller difference in the percent inocu-
lum bound (e.g., 1.0 versus 1.3) between the
PIP and PII+ variants was found in the radiola-
bel studies.
The third criterion indicating protein-mediat-
ed attachment is that a highly specific antibody
directed against the surface protein should inhib-
it attachment of the bacteria. Our gonococcal
attachment assays were performed with the
monospecific antibody 1090-10.1 (11). Light mi-
croscopy analysis demonstrated that the number
of HeLa cell-associated strain FA1090 PlIl
gonococcal units after incubation with monoclo-
nal antibody 1090-10.1 was less than the number
obtained after treatment with the control anti-
body 1035-4 (Table 2). These results indicated
that the PII-specific monoclonal antibody inhib-
ited the PII-mediated attachment to HeLa cells.
In the experiments with iodinated gonococci,
the number of HeLa cell-associated 1251I-labeled
strain FA1090 PII+ organisms was the same or
larger for organisms incubated with monoclonal
1090-10.1 than for those incubated with control
antibody 1035-4 (Table 1). Springer and Bar-
ondes (13) also noted an increase in intercellular
adhesion caused by an antibody directed against
the cell adhesion molecule. We used their tech-
nique for decreasing the agglutination and added
GAM Fab fragments to the monoclonal anti-
body-gonococci mixture. The GAM Fab de-
creased the number of gonococci present in the
gonococcal aggregates (Table 2) and reduced the
number of gonococcal units bound to the HeLa
cells. The number of HeLa cell-associated 1251_
labeled PII+ cells, after incubation with mono-
clonal antibody 1090-10.1 plus GAM Fab, was
significantly lower than that with control anti-
body 1035-4 plus GAM Fab for two of three
experiments (Table 1). The difference in results
may have been because a different GAM Fab
preparation was used in the third set of experi-
ments, stressing the importance of the specific
GAM Fab preparation.
Another source of variation was evident in the
experiments done to determine the optimal con-
centration of ascitic fluid protein for use in the
assays. It became apparent that the 1090-10.1
monoclonal antibody incubation and centrifuga-
tion steps caused overt aggregation of the organ-
isms. It appeared that the aggregation inhibited
the 125I-protein A from binding to the antibody
TABLE 2. Association of monoclonal antibody-treated gonococci with HeLa cells
Monoclo- No. of gonococcal Gonococcal units (% of total no.) with indi-Strain Mnolont- units per HeLa Inoculum cated no. of organisms per clump
(treament) body cells' (mean ± SD) (1"CUm) 1-2 3-5 6-8 9-15 .16
FA1090 PII+ 1090-10.1 ±1.66 0.20 2.2 38 21 16 11 15
b
FA1090 PII+ 1035-4 -3.75 ±0.45 2.7 74 20 3 2 0
FA1090 PIP- 1090-10.1 [1.81 t 0.27j 3.6 65 26 7 1 1
C d
FA1090 PII- 1035-4 -1.64 t 0.08 4.2 83 15 2 0 0
FA1090 PII+ 1090-10.1 1.09 ± 0.05 1.9 48 27 16 6 3
(GAM Fab)
a Each value is the mean of counts from three cover slips with a minimum of 100 LeLa cells counted per cover
slip ± standard deviation.
b p < 0.005 by Student's t test.
' No significant difference.
d P < 0.005 by Student's t test.
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molecules and resulted in the drop in counts per
minute per CFU at higher ascitic fluid protein
concentrations.
The relatively low levels of attachment for the
PII+ variant, 0.7 to 2.2% of the inoculum (Table
1), could be due to the eucaryotic cell substrate
used. Previously, Swanson et al. (15) showed
that a nonpiliated T4* colony type with the PIT
leukocyte association factor was substrate spe-
cific. They showed that 3.9% of the T4* inocu-
lum bound to human leukocytes, whereas only
1.9% of the inoculum bound to HeLa cells. The
strain FA1090 PII+ organism could exhibit this
type of substrate specificity; however, we did
not examine substrate specificity.
One strain of N. gonorrhoeae can make multi-
ple PITs, and these appear to be antigenically
heterogeneous (J. Swanson, Int. Conf. Path.
Neisseria, Montreal, Canada, August 1982). Ad-
ditionally, the different Plls appear to have
different eucaryotic cell attachment specificities
(7, 20). It is interesting that one strain of N.
gonorrhoeae can make a series of proteins, such
as the PITs, which may function both to circum-
vent immune response by antigenic variation
and possibly to enhance attachment to mucosal
cells at different anatomic sites in men and
women. Our studies have shown that monoclo-
nal antibodies are useful reagents for experi-
ments which will further the understanding of
these interesting N. gonorrhoeae characteris-
tics.
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